As inhibiting the interface between the SARS-CoV-2 spike protein and the GRP78 host-cell receptor reduces the rate of viral infection, developing a SARS-CoV-2 spike protein vaccine would almost certainly prevent viral infection [100]. The gene discussed is HSPA5; the disease is viral infectious disease.